Evidence map›Paper›PMID 39963300›Full record

ArticleJCEM case reports2025

Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the

Allison T Yip, Teresa H Kim, Esther M Peluso, Steven E Jacobsen, Michael W Yeh, Melissa G Lechner

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Allison T YipDivision of Endocrinology, Diabetes, and Metabolism, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
Teresa H KimDepartment of Pathology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
Esther M PelusoUCLA/Caltech Medical Scientist Training Program, UCLA Geffen School of Medicine, Los Angeles, CA 90095, USA.
Steven E JacobsenDepartment of Molecular, Cell and Developmental Biology, UCLA, Los Angeles, CA 90095, USA.
Michael W YehDepartment of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.ORCID https://orcid.org/0000-0001-7907-4245
Melissa G LechnerDivision of Endocrinology, Diabetes, and Metabolism, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.ORCID https://orcid.org/0000-0002-4744-6566

Funding

Mechanisms of Thyroid Autoimmunity in Checkpoint ImmunotherapyK08DK129829 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LECHNER, MELISSA G · 2021 to 2025
$878k
NIDDK NIH HHS K08 DK129829
6 · The paper itself

Abstract

Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor of the thyroid parafollicular C-cells associated with activating mutations in the rearranged during transfection (

Indexed as

germlinemedullary thyroid carcinomaMEN2pathogenic variantRET K666N

Identifiers

PMID39963300
PMCPMC11831074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.